Association between duration of tirofiban therapy before percutaneous intervention and tissue level perfusion (a TACTICS-TIMI 18 substudy) - 26/08/11
, Kanwar P. Singh, MD b, Sabina A. Murphy, MPH a, Peter M. DiBattiste, MD c, Laura A. Demopoulos, MD c, Christopher P. Cannon, MD a, Eugene Braunwald, MD aTIMI Study Group
Abstract |
In the setting of acute coronary syndromes, thrombotic embolization and activation of platelets with release of vasoconstrictors into the downstream microvasculature may occur before cardiac catheterization. In the Treat Angina with tirofiban and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18 (TACTICS-TIMI 18) trial angiographic substudy, a shorter duration of tirofiban infusion before percutaneous coronary intervention was associated with impaired myocardial perfusion before and after intervention.
Le texte complet de cet article est disponible en PDF.Vol 94 - N° 4
P. 492-494 - août 2004 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
